Non-alcoholic fatty liver disease (NAFLD) is the main cause of chronic liver disease
worldwide, affecting one-fourth of the world's population. With more than half of the world's …

The purpose of this study was to investigate the correlation between the severity of fatty liver
and factors such as gender, lifestyle, and the risks of metabolic abnormalities, inflammation …

Objetivo La esteatosis hepática no alcohólica (EHNA) es la causa más importante de
esteatosis hepática e hipertransaminasemia en los países occidentales. El objetivo …

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a
significant global health burden without established curative therapies. Early detection and …

Objective Nonalcoholic fatty liver disease (NAFLD) is western countries' most important
cause of hepatic steatosis and hypertransaminasemia. The objective was to evaluate the …

Background: India is currently facing an epidemic of type 2 diabetes mellitus (T2DM) and
obesity which are high-risk factors for the development of non-alcoholic fatty liver disease …

Background: The increasing prevalence of metabolic dysfunction-associated steatotic liver
disease (MASLD) has plagued the general population of the world, which has revised the …

Background: Cardiovascular diseases (CVD) and liver disorders, like Non-Alcoholic Fatty
Liver Disease (NAFLD), are major global health concerns, linked to significant morbidity and …

Methods: Three hundred and forty-one patients attending the master health checkup
between October 2022 and December 2022 at two centers were screened for fatty liver (FL) …

Introduction: The CAP (Controlled Attenuation Parameter) function of FibroScan® is a new
non-invasive diagnostic tool that allows the quantification of liver steatosis at the same time …